DFDA

Secondary Rhinoplasty / Orthognathic Surgery

Treatment for Orofacial Clefts

Effectiveness
82%
Safety Score
65%
Clinical Trials
600
Participants
60K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate post-op, final results develop over 6-12 months
Treatment Duration
Single surgery (3-6 hours), 4-8 weeks recovery
Evidence Quality
MODERATE
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$3,000
Side Effect Mgmt:$800
Total Annual:$3,900
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$97,500/QALY
QALYs Gained
1.8
Outcome-Based Costs
Cost per Responder
$4,432
Cost per Remission
$5,200
Secondary Rhinoplasty / Orthognathic Surgery Outcomes

for Orofacial Clefts

Efficacy Outcomes
Overall Effectiveness
+82%
Response Rate
+88%
Remission Rate
+75%
Common Side Effects
Swelling/Bruising
+100%
Asymmetry recurrence
+10%
Need for revision surgery
+20%
Sensory changes
+5%
Infection
+2%

Sources:

nih.gov
researchgate.net
dntb.gov.ua

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov